July 30, 2024
“Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by LSEG: The fast-food giant reported second-quarter net income of $2.02 billion, or $2.80 per share, down from $2.31 billion, or $3.15… Continue Reading…
March 23, 2021
“Iovance Biotherapeutics (IOVA)… The cutting edge med tech has attracted attention from Pantginis’ colleagues, as well. The stock has 5 recent reviews, and all are to Buy, making for a unanimous Strong Buy analyst consensus rating. IOVA has an average… Continue Reading…
January 27, 2020
“1. Have a solid emergency fund The one thing you need to remember about a stock market downturn is that you don’t lose money until you actually sell your investments at a loss. Imagine you buy a given stock at… Continue Reading…
Recent Comments